Home Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
Article Open Access

Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial

  • Dilek Hacıvelioğlu ORCID logo , Nurgül Güngör Tavşanlı ORCID logo , İrem Şenyuva ORCID logo EMAIL logo and Funda Kosova ORCID logo
Published/Copyright: February 24, 2023

Abstract

To evaluate the effect of delivery in a vertical birth chair (VBC) and traditional delivery table (DT) supported by women’s movement during labor on the labor process, fetal outcome, maternal hormone levels, birth comfort, and satisfaction. This randomized controlled trial was conducted with 1:1:1 allocation. Group 1: in the VBC in upright position, Group 2: on the DT in supine position, these groups supported by freedom of movement, control group: on the DT in supine position, labor in bed. The duration of second stage of labor was not different between the groups (p = 0.246). The occurrence of instrumental birth, episiotomy, and perineal laceration was also not different among the groups (p = 0.772, p = 0.953, and p = 0.124). The use of uterotonic was observed in control group (p = 0.001). 1 and 5 APGAR scores of newborns were not different in all groups (p = 0.121, p = 0.268). The lowest pain score was observed in Group 1 (p = 0.001). Birth comfort and satisfaction were higher in Group 1 (p = 0.001 and p = 0.001). Decreased postpartum prolactin levels and increased postpartum oxytocin levels were observed in the control and Group 1 (p = 0.004, p = 0.006). Freedom of movement during labor and delivery using VBC in upright position can play birth-promoting and supporting role. There were no negative effects on the fetal outcome.

1 Introduction

Freedom of movement during labor and delivery position affect motherhood, breastfeeding, and baby’s adaptation [1]. Maternal movements such as walking, squatting, leaning, etc. in the first stage of labor is critical for a favorable birth experience because it causes more uterine contractions, more maternal comfort, and less pain [2,3]. On the other hand, delivery positions (such as supine, recumbent, semi-recumbent, and upright) in the second stage of labor impact the labor progression, perineal injury, and maternal feeling [47].

Although supine position is associated with some advantages such as allowing the abdominal examination and aortic pressure assessment, it leads to pain and pelvic immobilization [7]. Upright position increases uterine blood flow, contractility, and pelvic outlet diameters, affecting the duration of labor [7]. Based on the advantages of the upright position, birth chairs (BCs), suitable for birth physiology, were designed such as AVE birthing bed and Birthing chairs-Magister Kebidanan (BC-MK15), and used throughout the world [7].

Endocrine system significantly affects the mother and baby during the delivery [8]. In a study on the evidence-based effects of the hormonal physiology on mothers and babies during birth, it was found that studies depending on the measurement of hormones should be prioritized to understand the beneficial or damaging effects of hormones in maternal care [9]. Oxytocin and prolactin (PRL) play a significant role during labor and in maintaining the health of the mother and baby; natural oxytocin increases uterine contraction, calmness, and reduce pain. Further, after delivery, oxytocin helps in lactation, while PRL plays role in the milk production and mother’s adaptations [1].

Although studies have been conducted to understand the effect of freedom of movement during labor and delivery positions (supine, traditional delivery table [DT] or upright, BCs) on the vaginal delivery, a study assessing the impact of the combination of maternal movement during labor and BC used during delivery is lacking. This study aimed to evaluate (1) the effect of use of vertical BC (VBC) [10] with upright position and traditional DT with supine position supported by women’s movement during labor on the labor process and birth outcomes, (2) birth comfort, satisfaction, and maternal hormones. The first null hypothesis was that there would be no significant differences between VBC and DT in terms of labor process and fetal outcomes, while the second null hypothesis was that there would be no significant differences between VBC and DT in terms of birth comfort, satisfaction, and maternal hormones.

2 Methods

2.1 Study design and participants

This randomized controlled trial included pregnant women who were 20–35 years of age, started the birth process at term, had no chronic illnesses, expected to give a normal birth without any obstetric risk, whose amniotic sac had not opened (mobility not hindered), and had not performed exercises during pregnancy. Pregnant women who had cesarean delivery due to indications or fetal distress during labor were excluded from the study.

2.2 Randomization

This was conducted between August 2019 and July 2020 in the maternity unit of a Usak Training and Research Hospital. Randomization was conducted according to the date of admission to the hospital for birth with 1:1:1 allocation. Pregnant women arriving on odd-numbered dates and meeting the criteria were included in the case groups, while those arriving on even-numbered dates were included in the control group. The groups were defined as follows: (1) traditional DT group consisted of women giving birth in the supine position, supported with freedom of movement and position during labor (n = 30), (2) VBC group consisted of women giving birth in the upright position, supported with freedom of movement and position during labor (n = 30), and (3) the control group, women with labor on the bed and delivery in the supine position (n = 30).

2.3 Data collection and intervention

After randomization, the case groups received instructions (approximately 30 min) under identical conditions using educational material showing movements, positions, and VBC (either visual or practical). In stage 1 of labor (after beginning, labor ends with full cervical dilation to 10 cm), the women were encouraged to move freely and take-up any position they want during the birth process, and included walking, squatting, sitting, leaning, and standing. They were also supported to make use of a pilates ball. When tired or monitoring or intervention was necessary, they were allowed to lie down for 10–15 min. At stage 2 of labor (completion of dilatation of the cervix to the delivery of the infant), women were brought to either VBC or the table for delivery. In the supine group, the birth occurred in the lithotomy position on the DT, with lying on the back, hips and knees bent, and legs supported with a stirrup. In the VBC group, the women’s back were brought to an angle of 60°. The women in the control group remained mostly on the bed during labor attached to electronic fetal monitorization, except when they used the toilet. The women in the control group did not receive any information on movements or positions.

In the VBC, the upright position depends on the angle made by the line joining the horizontal plane and the midpoints of the woman’s third and fifth lumbar vertebrae, and the angle should be more 45°. VBC is comfortable for pregnant women and suitable for the labor process and birth. It was created in Turkey in 2015 by Turkish researchers with the funding from the Scientific and Technological Research Council of Turkey [1012].

The data collection instruments for all the groups in the study included visual analog scale (VAS) to evaluate pain (VAS, 0–10 cm; 0, no pain; 10, severe pain).

Birth comfort scale (BCS) was used at the beginning and the end of stage 1 of labor. The scale evaluated the physical, psychospiritual, and environmental factors. The point score is minimum 9 and maximum 45; a higher score indicates comfort [13].

Birth satisfaction scale revised (BSS-R) form was provided to mothers 20–24 h after birth. This scale evaluated the quality of care, stress during labor, and women’s individual features. The score ranges from 0 to 40, and high scores demonstrate high satisfaction [14].

Maternal blood oxytocin and PRL levels were analyzed using ELISA method as described previously [15]. The blood samples were collected at the time of admission to the maternity unit and 24 h after birth.

Randomization, data collection, and interventions were carried out by two members of the research team (midwife; the first author) and obstetrician (the third author). Figure 1 shows the study flow-chart.

Figure 1 
                  Flow chart.
Figure 1

Flow chart.

We compared the data related to the labor process, fetal outcome, birth satisfaction, comfort, and maternal hormone levels.

  1. Ethical considerations: Permission for the research was obtained from the Health Sciences Ethics Committee of the Medical Faculty of Manisa Celal Bayar University (No. 10.07.2019/20.478.486) and Teaching and Research Hospital of Uşak University (No. 07.08.2019/45786011-612.01.99). The research was carried out in accordance with the Declaration of Helsinki. The women who agreed to take part in the study signed an Informed Voluntary Consent Form and an Approval Form for the Preservation of Biological Material for Educational and Research Purposes.

2.4 Statistical analysis

The program Number Cruncher Statistical System was used for statistical analysis. Kruskal–Wallis test and Dunn–Bonferroni test were used for comparisons between groups of more than two quantitative variables that did not show normal distribution. Wilcoxon signed-ranks test was used for in-group comparisons of quantitative variables that did not show normal distribution. Pearson chi-square test and Fisher–Freeman–Halton test were used to compare the qualitative data. Statistical significance was taken as p < 0.05.

Sample size calculation was performed with a computer application G*Power software (latest ver. 3.1.9.7). The calculation was performed by Cohen [16]. With the calculated effect size of 0.4, power 92%, and α error 0.05; the total sample size was 90.

3 Results

Ninety women were included in the study. Fifty percent of the women were primiparous and 50% were multiparous. No statistically significant difference was found between the groups in terms of gravida (p > 0.05). There were no differences between supine, VBC, and control group gestational weeks (39.33 ± 1.04, 39.02 ± 1.16, and 39.45 ± 1.07; p = 0.295). Table 1 shows the demographic characteristics of women.

Table 1

Demographic characteristics of women

Group 1 (n = 30) Group 2 (n = 30) Group 3 (n = 30) p
Min–max (mean ± SD) Min–max (mean ± SD) Min–max (mean ± SD)
Age 18–35 (25.60 ± 5.33) 19–34 (25.87 ± 4.55) 18–34 (26.70 ± 5.21) 0.679a
BMI (kg/m2) 16.6–31.3 (22.20 ± 4.22) 16–37.3 (22.91 ± 4.49) 17.9–36.7 (23.73 ± 4.03) 0.380a

BMI, body mass index; aOne-way ANOVA, bFisher–Freeman–Halton test.

3.1 Primary outcomes

3.1.1 Assessment of labor

There was no significant difference in the duration of second stage of labor between the groups (p = 0.246). No significant differences were seen among groups in terms of instrumental birth, episiotomy, and perineal laceration (p = 0.772, p = 0.953, and p = 0.124). The need of uterotonic (in the second stage of labor) was observed significantly (p = 0.001) more in the control group than that in the DT and VBC groups. Table 2 shows the data on the assessment of labor.

Table 2

Assessment of labor

Group 1 ( n = 30) Group 2 ( n = 30) Control ( n = 30) p
Min–max (mean ± SD) Min–max (mean ± SD) Min–max (mean ± SD)
Duration of second stage (min) 5–45 (20.5 ± 12.06) 5–35 (15 ± 8.41) 5–50 (18.23 ± 11.88) 0.246
Use of uterotonic (n, %) 2 (6.7) 4 (13.3) 14 (46.7) 0.001
Instrumental birth (n, %) 0 (0.0) 1 (3.3) 2 (6.7) 0.772
Episiotomy (n, %) 20 (66.7) 19 (63.3) 19 (63.3) 0.953
Perineal laceration (n, %) 0 (0.0) 4 (13.3) 4 (13.3) 0.124

3.1.2 Neonatal finding

No significant differences were observed among groups in APGAR scores (at 1 and 5 min, p = 0.121, p = 0.268). Further, birth weight was also not different among the groups (p = 0.909) (Table 3).

Table 3

Neonatal findings

Group 1 ( n = 30) Group 2 ( n = 30) Control ( n = 30) p
Min–max (mean ± SD) Min–max (mean ± SD) Min–max (mean ± SD)
1st min APGAR 8–9 (8.8 ± 0.41) 7–9 (8.73 ± 0.52) 7–9 (8.47 ± 0.73) 0.121
5th min APGAR 9–10 (9.8 ± 0.41) 8–10 (9.73 ± 0.52) 8–10 (9.57 ± 0.63) 0.268
Birth weight (g) 2,600–3,900 (3241.33 ± 371.05) 2,430–4,300 (3250.17 ± 436.17) 2,010–4,250 (3288.5 ± 515.64) 0.909

APGAR: appearance, pulse, grimace, activity, and respiration.

3.2 Secondary outcomes

3.2.1 Birth comfort

While comparing the second VAS score, the lowest score was observed in the VBC group (p = 0.001). Second measurement of BCS score was also significantly higher (p = 0.001) in the VBC group. Similarly, VBC group showed a significantly (p = 0.001) higher BSS-R score. Table 4 shows the birth comfort results.

Table 4

Evaluation of VAS, BCS, and BSS-R scores

Group 1 ( n = 30) Group 2 ( n = 30) Control ( n = 30) p
Min–max (mean ± SD) Min–max (mean ± SD) Min–max (mean ± SD)
VAS
First measurement 0–7 (4.1 ± 2.06) 2–7 (4.27 ± 1.17) 1–7 (4 ± 1.62) 0.757a
Second measurement 7–10 (8.7 ± 0.75) 7–10 (8.53 ± 0.82) 7–10 (9.4 ± 0.67) 0.001 b
Difference 4.60 ± 1.81 4.27 ± 1.36 5.40 ± 1.69
p 0.001 c 0.001 c 0.001 c 0.034 b
BCS
First measurement 27–44 (38.63 ± 4.44) 25–45 (37 ± 4.89) 30–45 (38.17 ± 5.19) 0.339b
Second measurement 28–45 (42.07 ± 3.26) 42–45 (44.77 ± 0.63) 26–39 (33.57 ± 3.78) 0.001 b
Difference 3.43 ± 4.73 7.77 ± 4.57 −4.60 ± 3.55
p 0.001 c 0.001 c 0.001 c 0.001 b
BSS-R 21–40 (31.03 ± 3.98) 22–37 (33.27 ± 3.56) 12–34 (21.37 ± 5.36) 0.001 b

VAS, visual analog scale; BCS, birth comfort scale; BSS-R, birth satisfaction score-revised. aOne-way ANOVA, bKruskal–Wallis test, cWilcoxon signed ranks test.

3.2.2 Maternal hormones

Control group showed significantly (p = 0.004) decreased levels of postpartum PRL, while a significant (p = 0.006) increase in the postpartum oxytocin levels was observed in the VBC group. Maternal hormone levels are shown in Table 5.

Table 5

Comparison of biochemical results

Group 1 ( n = 30) Group 2 ( n = 30) Control ( n = 30) p a
Min–max (mean ± SD) Min–max (mean ± SD) Min–max (mean ± SD)
PRL (ng/mL)
Before 34.48–580.35 (167.2 ± 140.45) 27.98–943.9 (196.85 ± 266.2) 64.23–523 (148.01 ± 108.36) 0.165
After 35.56–490 (190.61 ± 148.94) 29.61–1037.49 (222.31 ± 298.76) 82.08–534.9 (150.32 ± 119.39) 0.420
Difference −3.8 (−409 to 292.1) −3.79 (−197.5 to 44.9) 15.69 (−239.7 to 49.2)
p b 0.382 0.078 0.011 0.004 a
Oxytocin (pg/mL)
Before 11.9–188.62 (47.77 ± 43.76) 11.9–667.34 (100.35 ± 167.55) 13.22–150.37 (39.16 ± 32.61) 0.299
After 1.35–271.7 (68.08 ± 81.26) 26.41–829.56 (121.1 ± 205.99) −1.29–163.56 (40.65 ± 37.4) 0.034
Difference −1.32 (−230.8 to 38.2) −15.83 (−162.2 to 30.3) −6.59 (−26.3 to 34.3)
p b 0.264 0.006 0.784 0.146a

aKruskal–Wallis test, bWilcoxon signed ranks test.

4 Discussion

Upright position in delivery leads to reduced pressure on the abdominal aorta and increases the blood flow in the uterine vessels, resulting in high uterine contractility [7]. This position increases the pelvic pressure (approximately 30–50 mmHg) more than that of the supine position. Hence, the pressure on the cervix stimulates Ferguson reflex and enables oxytocin secretion in the brain [7]. On the other hand, with the upright position, the fetal move toward the pelvic outlet, sagittal diameter of pelvic outlet increases, and transient umbilical cord compression decreases [6,7,17].

Many BCs have been developed based on the advantages associated with the upright position [7]. Although previously designed BCs allowed upright position, they were not comfortable during and after delivery, women were required to be moved to a different table for episiotomy repair [5,6]. Currently designed BCs are compatible for physiological process of delivery and provide maternal comfort, with option of choosing different positions such as upright position during delivery and supine position during the episiotomy repair [7]. It has been suggested that the table angle must be 45° or more for decreasing the abdominal aortic pressure, generating high uterine blood supply, and contractility; however, traditional tables do not allow such angles [17].

Several studies have been conducted to demonstrate the effectiveness of BC and DT during delivery. Fitriani et al. reported that in BC, duration of second stage of labor was significantly lower than that of the DT group (20.67 ± 1.02 and 26.06 ± 1.08, respectively, p = 0.001) in multiparous women [7]. Perineal damage generally prolong second stage of labor and is related to congestion and edema, and all of these may lead to injury [5]. Low rates of episiotomy and perineal damage have been associated with use of BC during delivery [18,19]. In a study with 55 primiparous women in the third trimester related to the use of BC and DT, they did not observe 1 and 5 min APGAR scores abnormality for the two groups, which were 8.3–8.5 and 9.3–9.4 (p > 0.05) [4].

On the other hand, in Cochrane review 9015, pregnant women were evaluated (without epidural anesthesia), and delivery in BC and supine position were compared. No differences were observed in stage 2 labor and APGAR scores; however, they detected less episiotomy rates and high second-degree tear in BC group [20]. Crowley et al. evaluated 1,250 nulliparous women (no epidural anesthesia); they also did not observe any positive effect of BC during delivery and on prevention of perineal trauma [21].

The primary null hypothesis of this study could be partially accepted. In fact, we did not detect abnormal APGAR scores in all of the babies and it can be explained by inclusion of healthy pregnant women without any obstetrics risk during the antenatal follow-up. Further, we did not observe less duration of second stage of labor in all the groups, which may be due to small number of patients and mixed parity type. We also did not observe any perineal injury or high episiotomy rate in all the groups, possibly due to the absence of prolonged second stage of labor.

The feeling of satisfaction with birth is a multi-dimensional perception and includes the physical and psychosocial experience of birth [22]. It is reported that satisfaction in the birth process was associated with greater comfort [13]. Upright position with BC, freedom of movement during labor positively affect the oxytocin release and this hormone crosses the blood–brain barrier and leads to calmness, maternal delivery comfort, and less vulnerability [14,7,19,23]. Also, increased oxytocin level leads to alleviate pain and milk ejection, while increased PRL levels impact milk production and mother’s adaptation [1]. There was limited research on BC and maternal comfort in the literature. Shannahan and Cottrell studied 55 primiparous women and compared the maternal comfort levels of BC and DT; they found that BC users were more satisfied (BC = 3.52, DT = 3.17, p = 0.037) [4]. Crowley et al. evaluated 1,250 nulliparous women, they stated that women thought the experience was “not too unpleasant” 51% of BC and 45% DT [21]. Maternal freedom of movement during labor was recommended as Evidence grade-A [17]. This is because, in freedom of movement, women can attain different postures (such as standing, kneeling, squatting, etc.), leading to fetal head impinging on the internal body of the clitoris and releasing oxytocin and pain relief [3,24]. Walking during the first stage of labor reduces the need for an epidural anesthesia in terms of pain relief, according to clear and significant evidence found in Cochrane study 5218, which assessed pregnant women (RR = 0.81, 95% CI = 0.66–0.99, nine studies, 2,107 women; random effects, T2 = 0.02, I2 = 61%) [25]. In their meta-analysis of 533 pregnant women, Grenvik et al. found that the birthing ball group experienced much less labor pain than the control group (MD = 1.70 points; 95% CI = –2.20 to –1.20) [26]. Pain associated with vaginal delivery can increase mother’s stress and it is a risk factors for delayed lactogenesis [27]. Fifty-one pregnant women were evaluated by Karakoyunlu et al. for their first stage of labor VAS score, active phase perceived stress scale (PSS), and breastfeeding scale. There was a moderately negative correlation between stress and breastfeeding (breastfeeding scale = 6.56 ± 1.64, PSS = 48.13 ± 4.09, and VAS score = 9.21 ± 1.04) [28]. The secondary null hypothesis of this study could be rejected, although supported by free maternal movements in both the groups. VBC group showed lower VAS score and high birth comfort and satisfaction than that of the DT group. It can be explained by the combined effects of being upright, the high mother oxytocin level, and experiencing less pain. On the other hand, required uterotonic treatment, higher VAS score, and lower PRL levels were seen in the control group. It may be explained by negative effect of inactivity on birthing physiology, inability of synthetic oxytocin to cross the blood–brain barrier, and it does not have the same relaxing effect as natural oxytocin [1].

According to Cochrane review; upright position in the second stage of labor and freedom of movement during the first stage of labor are considered advantageous for mothers and babies [20,25]. Also, some evidence-based care practices about nursing/midwifery education promote physiological birth: avoiding unnecessary induction of labor, allowing freedom of movement for the laboring woman, providing continuous labor support, and keeping mothers and babies together after birth without restrictions on breastfeeding [29]. In terms of continuous labor support and obstetrics care quality, one-to-one care is recommended by the current guidelines [30,31]. In this aspect, we showed positive effect of delivery in a VBC supported by freedom of movement during labor. Midwives and obstetricians should support the mother’s movement and consider the upright position by using VBC. Therefore, midwives’ numbers should be increased and their duties should be arranged in the delivery room [30]. To reveal the true benefits and risk of this approach further comprehensive studies are needed.

Limitations of the study: A specific position was not examined; therefore, the results cannot be generalized to a single position. Some factors other than movement and position may also have an effect on the results (such as prenatal perineal release applications and pushing at birth). Because of ethical reasons, second blood sample was collected at 24 h postpartum. Pulsatile oxytocin releases during breastfeeding and promotes PRL release; PRL remains above baseline during the 24 h period and throughout early postpartum weeks [32,33]. All patients received painkillers (short acting non-steroidal anti-inflammatory drugs) immediately after delivery only one time. The half-life of these drugs is <6 h [34], and we collected second blood sample after 24 h of delivery.

5 Conclusions

In this study, we demonstrated that freedom of movement during labor and delivery using BC in upright position positively affect the postpartum maternal hormone levels, decrease pain, increase birth comfort, and satisfaction, without any adverse effect on labor, birth, and fetal outcomes. Thus, freedom of movement combined with use of BC during labor can have satisfactory results during the vaginal birth.


tel: +90-0533 571 24 46

Acknowledgments

The authors would like to thank to Emire Bor to statistical analyses.

  1. Funding information: This study was supported by the Scientific Research Projects Commission of Manisa Celal Bayar University with the project numbered 2019-163.

  2. Author contributions: D.H.: design of the work, clinical trial, data analyzing, literature search, and writing: I.S.: clinical trial, literature search, writing, and final check; N.G.T.: design of the work; F.K.: data analyzing, laboratuvar, and analyzing. All authors have accepted the responsibility for the entire content of this manuscript and approved its submission.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

References

[1] Bonapace J, Gagné GP, Chaillet N, Gagnon R, Hébert E, Buckley S. Physiologic basis of pain in labour and delivery: an evidence-based approach to its management. J Obstet Gynaecol Can. 2018;40(2):227–45.10.1016/j.jogc.2017.08.003Search in Google Scholar PubMed

[2] Fox D, Maude R, Coddington R, Woodworth R, Scarf V, Watson K, et al. The use of continuous foetal monitoring technologies that enable mobility in labour for women with complex pregnancies: a survey of Australian and New Zealand hospitals. Midwifery. 2021;93:102887.10.1016/j.midw.2020.102887Search in Google Scholar PubMed

[3] Jowitt M. Electronic fetal monitoring is more important than freedom of maternal position in labour: AGAINST: a biomechanical model of labour suggests that maternal freedom of movement is critical for a good birth. BJOG. 2018;125(7):894.10.1111/1471-0528.15026Search in Google Scholar PubMed

[4] Shannahan MK, Cottrell BH. The effects of birth chair delivery on maternal perceptions. J Obstet Gynecol Neonatal Nurs. 1989;18(4):323–6. 10.1111/j.1552-6909.1989.tb01626.x.Search in Google Scholar PubMed

[5] Liddell HS, Fisher PR. The birthing chair in the second stage of labour. Aust N Z J Obstet Gynaecol. 1985;25(1):65–8.10.1111/j.1479-828X.1985.tb00607.xSearch in Google Scholar PubMed

[6] Stewart P, Hillan E, Calder AA. A randomised trial to evaluate the use of a birth chair for delivery. Lancet. 1983;1(8337):1296–8.10.1016/S0140-6736(83)92412-1Search in Google Scholar PubMed

[7] Fitriani F, Mose JC, Herman H. Difference duration of labor at BC-MK15 birth chairwith conventional bed in multiparous. GMHC. 2018;6(2):105–12.Search in Google Scholar

[8] Latendresse G. The interaction between chronic stress and pregnancy: preterm birth from a biobehavioral perspective. J Midwifery Womens Health. 2009;54(1):8–17.10.1016/j.jmwh.2008.08.001Search in Google Scholar PubMed PubMed Central

[9] Buckley SJ. Hormonal physiology of childbearing: evidence and implications for women, babies, and maternity care. Washington, DC: Childbirth Connection Programs, National Partnership for Women & Families; 2015. https://www.nationalpartnership.org/our-work/resources/health-care/maternity/hormonal-physiology-of-childbearing.pdf.10.1891/1058-1243.24.3.145Search in Google Scholar PubMed PubMed Central

[10] The Scientific and Technological Research Council of Turkey (TUBITAK). Normal Doğum Yapmak Artık Çok Kolay. [Updated 2017 March 18, cited:2022 Sep 03]. https://www.tubitak.gov.tr/tr/haber/normal-dogumyapmak-artik-cok-kolay.Search in Google Scholar

[11] Desseauve D, Fradet L, Lacouture P, Pierre F. Position for labor and birth: state of knowledge and biomechanical perspectives. Eur J Obstet Gynecol Reprod Biol. 2017;208:46–54.10.1016/j.ejogrb.2016.11.006Search in Google Scholar PubMed

[12] Huang J, Zang Y, Ren LH, Li FJ, Lu H. A review and comparison of common maternal positions during the second-stage of labor. Int J Nurs Sci. 2019;6(4):460–7.10.1016/j.ijnss.2019.06.007Search in Google Scholar PubMed PubMed Central

[13] Bryar R, Sinclair M. Theory for midwifery practice. In: Schuiling KD, Sampslelle C, Kolcaba K, editors. Exploring the presence of comfort within the context of childbirth. 2nd edn. USA: Bloomsbury Publishing; 2011. p. 197–212.10.1007/978-0-230-34563-8_9Search in Google Scholar

[14] Hollins Martin CJ, Martin CR. Development and psychometric properties of the Birth Satisfaction Scale-Revised (BSS-R). Midwifery. 2014;30(6):610–9.10.1016/j.midw.2013.10.006Search in Google Scholar PubMed

[15] Leng G, Sabatier N. Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers. J Neuroendocrinol. 2016;28(10):10.10.1111/jne.12413Search in Google Scholar PubMed PubMed Central

[16] Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates; 1998.Search in Google Scholar

[17] Cottrell BH, Shannahan MK. A comparison of fetal outcome in birth chair and delivery table births. Res Nurs Health. 1987;10(4):239–43.10.1002/nur.4770100406Search in Google Scholar PubMed

[18] Scholz HS, Benedicic C, Arikan MG, Haas J, Petru E. Spontaneous vaginal delivery in the birth-chair versus in the conventional dorsal position: a matched controlled comparison. Wien Klin Wochenschr. 2001;113(17–18):695–7.Search in Google Scholar

[19] Storton S. Step 4: provides the birthing woman with freedom of movement to walk, move, assume positions of her choice: the coalition for improving maternity services. J Perinat Educ. 2007;16(1):25S–7S.10.1624/105812407X173164Search in Google Scholar PubMed PubMed Central

[20] Gupta JK, Sood A, Hofmeyr GJ, Vogel JP. Position in the second stage of labour for women without epidural anaesthesia. Cochrane Database Syst Rev. 2017;5(5):CD002006.10.1002/14651858.CD002006.pub4Search in Google Scholar PubMed PubMed Central

[21] Crowley P, Elbourne D, Ashurst H, Garcia J, Murphy D, Duignan N. Delivery in an obstetric birth chair: a randomized controlled trial. Br J Obstet Gynaecol. 1991;98(7):667–74.10.1111/j.1471-0528.1991.tb13453.xSearch in Google Scholar PubMed

[22] Priddis H, Dahlen H, Schmied V. What are the facilitators, inhibitors, and implications of birth positioning? A review of the literature. Women Birth. 2012;25(3):100–6.10.1016/j.wombi.2011.05.001Search in Google Scholar PubMed

[23] Nokomis Z. Relationship between Ambulation and Position Changes during Labor and Hormonal Physiology of Childbearing [Honors Theses]. WMU: Bronson School of Nursing; 2016.Search in Google Scholar

[24] Abdolahian S, Ghavi F, Abdollahifard S, Sheikhan F. Effect of dance labor on the management of active phase labor pain & clients’ satisfaction: a randomized controlled trial study. Glob J Health Sci. 2014;6(3):219–26.10.5539/gjhs.v6n3p219Search in Google Scholar PubMed PubMed Central

[25] Lawrence A, Lewis L, Hofmeyr GJ, Dowswell T, Styles C. Maternal positions and mobility during first stage labour. Cochrane Database Syst Rev. 2009 Apr 15;2:CD003934.10.1002/14651858.CD003934.pub2Search in Google Scholar PubMed PubMed Central

[26] Grenvik JM, Rosenthal E, Wey S, Saccone G, De Vivo V, De Prisco Lcp A, et al. Birthing ball for reducing labor pain: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2021;21:1–10.10.1080/14767058.2021.1875439Search in Google Scholar PubMed

[27] Chen DC, Nommsen-Rivers L, Dewey KG, Lönnerdal B. Stress during labor and delivery and early lactation performance. Am J Clin Nutr. 1998;68(2):335–44.10.1093/ajcn/68.2.335Search in Google Scholar PubMed

[28] Karakoyunlu Ö, Ejder Apay S, Gürol A. The effect of pain, stress, and cortisol during labor on breastfeeding success. Dev Psychobiol. 2019;61(7):979–87.10.1002/dev.21873Search in Google Scholar PubMed

[29] Romano AM, Lothian JA. Promoting, protecting, and supporting normal birth: a look at the evidence. J Obstet Gynecol Neonatal Nurs. 2008;37(1):94–104.10.1111/j.1552-6909.2007.00210.xSearch in Google Scholar PubMed

[30] Sfregola G, Laganà AS, Granese R, Sfregola P, Lopinto A, Triolo O. Work load and management in the delivery room: changing the direction of healthcare policy. J Obstet Gynaecol. 2017;37(2):185–90.10.1080/01443615.2016.1229276Search in Google Scholar PubMed

[31] Franchi M, Parissone F, Lazzari C, Garzon S, Laganà AS, Raffaelli R, et al. Selective use of episiotomy: what is the impact on perineal trauma? Results from a retrospective cohort study. Arch Gynecol Obstet. 2020;301(2):427–35.10.1007/s00404-019-05404-5Search in Google Scholar PubMed

[32] Huang SK, Chih MH. Increased breastfeeding frequency enhances milk production and infant weight gain: correlation with the basal maternal prolactin level. Breastfeed Med. 2020;15(10):639–45.10.1089/bfm.2020.0024Search in Google Scholar PubMed

[33] Sakala C, Romano AM, Buckley SJ. Hormonal physiology of childbearing, an essential framework for maternal–newborn nursing. J Obstet Gynecol Neonatal Nurs. 2016;45:264–75.10.1016/j.jogn.2015.12.006Search in Google Scholar PubMed

[34] Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147.10.1016/j.bcp.2020.114147Search in Google Scholar PubMed PubMed Central

Received: 2022-09-03
Revised: 2022-11-12
Accepted: 2022-12-11
Published Online: 2023-02-24

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Downloaded on 29.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0633/html?lang=en
Scroll to top button